These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35934396)

  • 1. A glutathione activatable bioprobe for detection of hepatocellular carcinoma cells in peripheral blood via carbohydrate-protein interaction.
    Wang Y; Li J; Pei Z; Pei Y
    Anal Chim Acta; 2022 Aug; 1221():340106. PubMed ID: 35934396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Dual-Targeting Functionalized Graphene Film for Rapid and Highly Sensitive Fluorescence Imaging Detection of Hepatocellular Carcinoma Circulating Tumor Cells.
    Wu C; Li P; Fan N; Han J; Zhang W; Zhang W; Tang B
    ACS Appl Mater Interfaces; 2019 Dec; 11(48):44999-45006. PubMed ID: 31714050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease.
    Li YM; Xu SC; Li J; Han KQ; Pi HF; Zheng L; Zuo GH; Huang XB; Li HY; Zhao HZ; Yu ZP; Zhou Z; Liang P
    Cell Death Dis; 2013 Oct; 4(10):e831. PubMed ID: 24091674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating tumor cells in hepatocellular carcinoma using antibodies against asialoglycoprotein receptor, carbamoyl phosphate synthetase 1 and pan-cytokeratin.
    Li J; Chen L; Zhang X; Zhang Y; Liu H; Sun B; Zhao L; Ge N; Qian H; Yang Y; Wu M; Yin Z
    PLoS One; 2014; 9(4):e96185. PubMed ID: 24763545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
    Court CM; Hou S; Winograd P; Segel NH; Li QW; Zhu Y; Sadeghi S; Finn RS; Ganapathy E; Song M; French SW; Naini BV; Sho S; Kaldas FM; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG
    Liver Transpl; 2018 Jul; 24(7):946-960. PubMed ID: 29624843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A GLUTs/GSH cascade targeting-responsive bioprobe for the detection of circulating tumor cells.
    Wang Y; Li J; Chen Z; Pu L; Pei Z; Pei Y
    Chem Commun (Camb); 2022 Mar; 58(24):3945-3948. PubMed ID: 35244637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved method increases sensitivity for circulating hepatocellular carcinoma cells.
    Liu HY; Qian HH; Zhang XF; Li J; Yang X; Sun B; Ma JY; Chen L; Yin ZF
    World J Gastroenterol; 2015 Mar; 21(10):2918-25. PubMed ID: 25780289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microfluidic chip for isolation of viable circulating tumor cells of hepatocellular carcinoma for their culture and drug sensitivity assay.
    Zhang Y; Zhang X; Zhang J; Sun B; Zheng L; Li J; Liu S; Sui G; Yin Z
    Cancer Biol Ther; 2016 Nov; 17(11):1177-1187. PubMed ID: 27662377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamer-Mediated Transparent-Biocompatible Nanostructured Surfaces for Hepotocellular Circulating Tumor Cells Enrichment.
    Wang S; Zhang C; Wang G; Cheng B; Wang Y; Chen F; Chen Y; Feng M; Xiong B
    Theranostics; 2016; 6(11):1877-86. PubMed ID: 27570557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of circulating tumor cells in patients with hepatocellular carcinoma using a novel cell separation strategy.
    Xu W; Cao L; Chen L; Li J; Zhang XF; Qian HH; Kang XY; Zhang Y; Liao J; Shi LH; Yang YF; Wu MC; Yin ZF
    Clin Cancer Res; 2011 Jun; 17(11):3783-93. PubMed ID: 21527564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-Selective and Dual-Enhanced SERS Nanoprobes Strategy for Circulating Hepatocellular Carcinoma Cells Detection.
    Pang Y; Wang C; Xiao R; Sun Z
    Chemistry; 2018 May; 24(27):7060-7067. PubMed ID: 29521467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biofunctionalized magnetic nanospheres-based cell sorting strategy for efficient isolation, detection and subtype analyses of heterogeneous circulating hepatocellular carcinoma cells.
    Chen L; Wu LL; Zhang ZL; Hu J; Tang M; Qi CB; Li N; Pang DW
    Biosens Bioelectron; 2016 Nov; 85():633-640. PubMed ID: 27240010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor cells in hepatocellular carcinoma: detection techniques, clinical implications, and future perspectives.
    Zhang Y; Li J; Cao L; Xu W; Yin Z
    Semin Oncol; 2012 Aug; 39(4):449-60. PubMed ID: 22846862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.
    Kelley RK; Magbanua MJ; Butler TM; Collisson EA; Hwang J; Sidiropoulos N; Evason K; McWhirter RM; Hameed B; Wayne EM; Yao FY; Venook AP; Park JW
    BMC Cancer; 2015 Mar; 15():206. PubMed ID: 25884197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma.
    Ahn JC; Teng PC; Chen PJ; Posadas E; Tseng HR; Lu SC; Yang JD
    Hepatology; 2021 Jan; 73(1):422-436. PubMed ID: 32017145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients.
    Chen J; Cao SW; Cai Z; Zheng L; Wang Q
    Cancer Biomark; 2017 Dec; 20(4):487-498. PubMed ID: 28869439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma.
    Sun YF; Guo W; Xu Y; Shi YH; Gong ZJ; Ji Y; Du M; Zhang X; Hu B; Huang A; Chen GG; Lai PBS; Cao Y; Qiu SJ; Zhou J; Yang XR; Fan J
    Clin Cancer Res; 2018 Feb; 24(3):547-559. PubMed ID: 29070526
    [No Abstract]   [Full Text] [Related]  

  • 18. Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
    Zhou J; Zhang Z; Zhou H; Leng C; Hou B; Zhou C; Hu X; Wang J; Chen X
    BMC Cancer; 2020 Oct; 20(1):1047. PubMed ID: 33129301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capturing circulating tumor cells of hepatocellular carcinoma.
    Wu LJ; Pan YD; Pei XY; Chen H; Nguyen S; Kashyap A; Liu J; Wu J
    Cancer Lett; 2012 Dec; 326(1):17-22. PubMed ID: 22842097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New Cell Block Method for Multiple Immunohistochemical Analysis of Circulating Tumor Cells in Patients with Liver Cancer.
    Nam SJ; Yeo HY; Chang HJ; Kim BH; Hong EK; Park JW
    Cancer Res Treat; 2016 Oct; 48(4):1229-1242. PubMed ID: 27034142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.